Novel chimeric monoclonal antibodies that block fentanyl effects and alter fentanyl biodistribution in mice

Novel chimeric monoclonal antibodies that block fentanyl effects and alter fentanyl biodistribution in mice

The prevalence and societal impact of opioid use disorder (OUD) is an acknowledged public health crisis that is further aggravated by the current pandemic. One of the devastating consequences of OUD is opioid overdose deaths. While multiple medications are now available to treat OUD, given the preva...

Full description

Bibliographic Details
Main Authors: Bhupal Ban, Rodell C. Barrientos, Therese Oertel, Essie Komla, Connor Whalen, Megan Sopko, Yingjian You, Partha Banerjee, Agnieszka Sulima, Arthur E. Jacobson, Kenner C. Rice, Gary R. Matyas, Vidadi Yusibov
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:mAbs
Subjects:
Fentanyl mAb
passive immunization
opioid use disorder
opioids
fentanyl analogs
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2021.1991552

Internet

https://www.tandfonline.com/doi/10.1080/19420862.2021.1991552

Similar Items